Abeta-IN-6 is an orally bioavailable small molecule for Alzheimers disease research. It exhibits neuroprotective properties by inhibiting Abeta oligomerization, reducing microglial cytokine release, and activating the Nrf2 antioxidant pathway, as demonstrated in both cellular and in vivo oxidative stress models.
Molecular Weight:
473.56
Formula:
C28H31N3O4
Target:
Others,Beta Amyloid,Nrf2
* VAT and and shipping costs not included. Errors and price changes excepted
